NSE: OSWALSEEDS
SHREEOSWAL S AND CHE LTD
Operates two divisions handling psyllium and seeds, generating consolidated revenue of Rs 248.23 crore in FY26. The Psyllium Division contributed Rs 137.11 crore (55.2% of segment revenue) with segment EBIT of Rs 9.62 crore, while the Seeds Division contributed Rs 111.12 crore (44.8% share) with EBIT of Rs 4.27 crore. Raw materials accounted for 98.6% of revenue, indicating the cost base is dominated by inputs rather than processing value-add. Employee costs were 1.6% of revenue, other operating expenses 2.3%, and depreciation 0.3%. The business runs an export subsidiary, ShreeOswal Psyllium Exports India Limited, which handles overseas sales of psyllium. FY26 net profit was Rs 7.22 crore with an EBITDA margin of 6% and total assets of Rs 140.54 crore. AR · MarketPing reader · 2026-08-02
Revenue streams, as the annual report describes them. Psyllium Division (55%), Seeds Division (45%). Agricultural commodity business split across two divisions, with material costs dominating the cost structure
Exhibit 1: Financial summary, FY23–FY26 (all audited; no estimate years)
| ₹ crore · consolidated | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|
| Revenue | 272 | 269 | 246 | 248 |
| EBITDA (ex other income) | 12 | 1 | 10 | 15 |
| margin % | 4.4 | 0.4 | 3.9 | 5.9 |
| Owners' profit | 6 | (4) | 4 | 7 |
| EPS, as reported (₹) | 3.74 | (0.45) | 0.39 | 0.79 |
| ROE % · ROCE % | 12.9 · 24.9 | (10.3) · 1.4 | 8.1 · 20.4 | 14.2 · 26.5 |
| Debt / equity (x) | 0.92 | 1.59 | 0.96 | 1.21 |
| Cash from operations | 12 | (15) | 24 | (14) |
| Capex | (2) | (3) | (0) | (1) |
Exhibit 2: Quarterly performance, last 8 quarters
| ₹ crore | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 | Q1 FY27 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 68 | 75 | 26 | 98 | 39 | 55 | 56 | 117 |
| Profit before tax | 0 | 7 | 1 | 10 | (5) | 1 | 3 | 17 |
| Net profit | 0 | 5 | 1 | 7 | (3) | 1 | 2 | 12 |
| EPS (₹) | 0.04 | 0.59 | 0.06 | 0.80 | (0.35) | 0.11 | 0.23 | 1.34 |
Exhibit 3: Segment revenue, FY26
| Segment | Revenue, ₹ crore | Share % |
|---|---|---|
| Seeds Division | 78 | 31.2 |
| Psyllium Division | 116 | 46.7 |
| SEEDS DIVISION | 34 | 13.5 |
| PSYLLIUM DIVISION | 21 | 8.5 |
| Total, before eliminations | 248 | 100.0 |
Exhibit 4: Peers — basic industry group, by market cap
| Company | M.cap ₹ cr | P/E | P/B | EV/EBITDA | ROE % | ROCE % | Rev CAGR 5y % | EBITDA m. % |
|---|---|---|---|---|---|---|---|---|
| LT FOODS LIMITED | 13,579 | 21.2 | 3.00 | 11.6 | 13.8 | 16.0 | 18.7 | 11.5 |
| KRBL LIMITED | 8,108 | 10.7 | 1.40 | 8.4 | 11.2 | 14.7 | 8.8 | 24.9 |
| GUJARAT AMBUJA EXPORTS LT | 6,628 | 15.9 | 2.01 | 12.4 | 9.2 | 11.7 | 4.0 | 17.0 |
| KAVERI SEED CO. LTD. | 3,503 | 14.2 | 2.00 | 9.4 | 16.9 | 17.0 | 6.1 | 40.1 |
| TRUALT BIOENERGY LIMITED | 3,301 | 23.5 | 2.09 | 12.9 | 6.1 | 4.8 | — | 23.5 |
| INDRAYANI BIOTECH LTD. | 2,984 | 22.4 | 29.23 | 218.8 | 1.9 | 0.2 | 45.6 | 8.2 |
| AMIR CHAND JAG KUM (E) L | 2,249 | 21.5 | 2.43 | 13.1 | 11.2 | 14.8 | — | 9.5 |
| GRM OVERSEAS LIMITED | 1,823 | 13.9 | 3.01 | 17.1 | 12.3 | 16.5 | 17.2 | 8.4 |
Exhibit 5: Where the company sits in its group
| Metric | Company | Group median | Rank | Better than |
|---|---|---|---|---|
| P/E (TTM) | 8.2 | 12.3 | 15 of 53 | 73% |
| P/B | 2.0 | 1.6 | 29 of 51 | 44% |
| ROCE | 17.9 | 4.1 | 10 of 67 | 86% |
| ROE | 14.2 | 3.5 | 9 of 51 | 84% |
| Debt / Equity | 1.2 | 0.4 | 42 of 51 | 18% |
| EBITDA margin | 15.7 | 9.7 | 14 of 45 | 71% |
| Revenue growth | 19.5 | 10.3 | 19 of 51 | 64% |
| Profit growth | 68.6 | 16.6 | 18 of 51 | 66% |
| Market cap | 100 | 66 | 32 of 69 | 54% |
Exhibit 6: Filings of the last 90 days, with the measured price reaction
| Date · filing | Category | Importance | Next day % | 5-day % |
|---|---|---|---|---|
| 13 Oct 2026 · Non-applicability of Regulation 74(5) compliance certificate for Q2 FY26 | compliance | minimal | — | — |
| 8 Oct 2026 · ShreeOswal Seeds clarifies on unusual share price movement | regulatory legal | medium | — | — |
| 28 Sept 2026 · Trading Window Closure from Oct 1 for Q2 Results | compliance | minimal | — | — |
| 26 Sept 2026 · Board re-appointments and new statutory auditor confirmed at AGM | management changes | medium | — | — |
| 26 Sept 2026 · AGM approves re-appointment of Chairman and CEO; new statutory auditor appointed | management changes | high | — | — |
| 26 Sept 2026 · CMD, CEO and Independent Director re-appointed at AGM | management changes | medium | — | — |
| 26 Sept 2026 · AGM approves new statutory auditor and director re-appointments | management changes | medium | — | — |
| 26 Sept 2026 · AGM 2026 voting results: All 6 resolutions approved | board shareholder meetings | low | — | — |
| 25 Sept 2026 · ShreeOswal Seeds 9th AGM held on Sept 25, 2026 - 6 resolutions transacted | board shareholder meetings | low | — | — |
| 15 Sept 2026 · NSE seeks clarification from company on unusual price movement | compliance | low | — | — |
How to read this document
| Where a broker report shows | This document shows | Why |
|---|---|---|
| A rating (BUY / ADD / REDUCE / SELL) | A state: the latest filed quarter and the measured reactions | an event is a fact; a rating is an opinion that requires SEBI RA registration |
| A target price and upside | The current price and the multiples against the group | a target is a forecast; a multiple is a measurement |
| Estimate years marked E | More audited years; no estimates | MarketPing publishes no forecasts — your own model lives on the Models page |
Sources, method and disclosures
This document is a statistical summary of publicly filed information and market data, prepared by software from primary sources: SEBI results XBRL filed with BSE and NSE, LODR disclosures, shareholding patterns, exchange price data. It contains no research recommendation, no price target and no opinion on the merits of any security, and is not a research report within the meaning of the SEBI (Research Analysts) Regulations, 2014, Regulation 2(1)(w)(vii). Financial statements are as filed (consolidated where the company files consolidated results). Ratios are computed over filed lines. Where a figure is unavailable the table shows a dash rather than an estimate. The business brief is written by MarketPing's reader from the annual report and checked against it; no figure in a table was generated by a model. Nothing here constitutes investment advice, an offer or a solicitation; readers should consult a SEBI-registered adviser before acting. MarketPing is not a SEBI-registered intermediary.